Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$225.16
-2.4%
$233.02
$149.04
$251.71
$555.59B0.277.02 million shs13.90 million shs
Kenvue Inc. stock logo
KVUE
Kenvue
$17.29
-2.0%
$17.40
$14.02
$23.90
$33.87B0.5519.40 million shs33.79 million shs
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
$53.66
-0.6%
$53.46
$49.41
$57.65
$6.09B0.871.44 million shs735,933 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-2.54%-4.05%-0.94%-9.50%+47.62%
Kenvue Inc. stock logo
KVUE
Kenvue
-2.15%-1.48%+0.46%-9.53%-26.60%
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
-0.61%-0.47%+0.08%-6.34%+7.91%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$225.16
-2.4%
$233.02
$149.04
$251.71
$555.59B0.277.02 million shs13.90 million shs
Kenvue Inc. stock logo
KVUE
Kenvue
$17.29
-2.0%
$17.40
$14.02
$23.90
$33.87B0.5519.40 million shs33.79 million shs
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
$53.66
-0.6%
$53.46
$49.41
$57.65
$6.09B0.871.44 million shs735,933 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-2.54%-4.05%-0.94%-9.50%+47.62%
Kenvue Inc. stock logo
KVUE
Kenvue
-2.15%-1.48%+0.46%-9.53%-26.60%
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
-0.61%-0.47%+0.08%-6.34%+7.91%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.74
Moderate Buy$253.0412.38% Upside
Kenvue Inc. stock logo
KVUE
Kenvue
2.31
Hold$19.3311.85% Upside
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
2.49
Hold$53.66N/A

Current Analyst Ratings Breakdown

Latest KVUE, JNJ, and NOBL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UpgradeHoldOutperform
5/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UpgradeMarket PerformOutperform$265.00
5/8/2026
Kenvue Inc. stock logo
KVUE
Kenvue
UpgradeHold (C-)Hold (C)
5/8/2026
Kenvue Inc. stock logo
KVUE
Kenvue
UpgradeHoldStrong-Buy
4/24/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy (B+)Buy (B)
4/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetBuy$244.00 ➝ $266.00
4/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetBuy$240.00 ➝ $275.00
4/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetOutperform$237.00 ➝ $246.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Set Price Target$283.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Reiterated RatingOutperform$265.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetHold$220.00 ➝ $250.00
(Data available from 5/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B5.75$13.77 per share16.35$33.73 per share6.68
Kenvue Inc. stock logo
KVUE
Kenvue
$15.12B2.19$1.35 per share12.79$5.53 per share3.13
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$8.6526.0317.902.2621.83%32.60%13.29%7/15/2026 (Estimated)
Kenvue Inc. stock logo
KVUE
Kenvue
$1.47B$0.8520.3414.051.3410.61%20.81%8.21%8/6/2026 (Estimated)
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
N/AN/A21.15N/AN/AN/AN/AN/AN/A

Latest KVUE, JNJ, and NOBL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Kenvue Inc. stock logo
KVUE
Kenvue
$0.27$0.32+$0.05$0.25$3.84 billion$3.91 billion
4/14/2026Q1 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.362.38%+5.25%61.97%64 Years
Kenvue Inc. stock logo
KVUE
Kenvue
$0.834.80%N/A97.65%1 Years
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
$2.123.95%N/AN/AN/A

Latest KVUE, JNJ, and NOBL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/14/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.33%5/26/20265/26/20266/9/2026
4/29/2026
Kenvue Inc. stock logo
KVUE
Kenvue
quarterly$0.20754.82%5/13/20265/13/20265/27/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.46
1.03
0.77
Kenvue Inc. stock logo
KVUE
Kenvue
0.67
0.98
0.70
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Kenvue Inc. stock logo
KVUE
Kenvue
97.64%
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
N/A

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Kenvue Inc. stock logo
KVUE
Kenvue
1.59%
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Kenvue Inc. stock logo
KVUE
Kenvue
22,0001.92 billion1.89 billionOptionable
ProShares S&P 500 Aristocrats ETF stock logo
NOBL
ProShares S&P 500 Aristocrats ETF
N/A113.40 millionN/ANot Optionable

Recent News About These Companies

ProShares Leaders Q&A on Dividend Aristocrat Suite
Best Dividend Aristocrats As Of March 20, 2026

New MarketBeat Followers Over Time

Media Sentiment Over Time

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$225.16 -5.64 (-2.44%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$225.42 +0.25 (+0.11%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Kenvue stock logo

Kenvue NYSE:KVUE

$17.28 -0.36 (-2.01%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$17.34 +0.05 (+0.32%)
As of 05/29/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

ProShares S&P 500 Aristocrats ETF stock logo

ProShares S&P 500 Aristocrats ETF BATS:NOBL

$53.66 -0.33 (-0.61%)
As of 05/29/2026 04:10 PM Eastern

The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) is an exchange-traded fund that is based on the S&P 500 Dividend Aristocrats index. The fund tracks an equal-weighted index of S&P 500 constituents that have increased dividend payments annually for at least 25 years. NOBL was launched on Oct 9, 2013 and is managed by ProShares.